Rubicon Research Limited (NSE:RUBICON)
773.60
-17.00 (-2.15%)
At close: Mar 25, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 127.45 billion as of March 26, 2026.
Market Cap
127.45B
Enterprise Value
131.61B
Revenue
15.98B
Ranking
n/a
PE Ratio
59.35
Stock Price
773.60
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 127.45B, an increase of 23.15%. That is a compound annual growth rate of 60.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 127.45B | 13.64% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 390.99B |
| J. B. Chemicals & Pharmaceuticals | 333.26B |
| AstraZeneca Pharma India | 207.25B |
| Granules India | 150.80B |
| Jubilant Pharmova | 136.08B |
| Caplin Point Laboratories | 120.65B |
| CORONA Remedies | 96.19B |
| Viyash Scientific | 82.49B |